Coffee Compound Fights Colon Cancer

A team of Japanese researchers has pinpointed a molecular mechanism by which caffeic acid, a compound present in coffee, can suppress colorectal cancer cell growth. This discovery offers promising implications for developing new cancer prevention and treatment strategies.

The study focused on caffeic acid, a breakdown product of polyphenols abundant in coffee. Experiments showed that caffeic acid significantly suppressed the formation of cancer cell colonies. Further analysis revealed that caffeic acid directly binds to a protein known as RPS5, which is linked to a poorer prognosis for colorectal cancer patients.

This binding action inhibits RPS5 function, leading to a reduction in cyclin D1 levels. Cyclin D1 is crucial for cell cycle progression. The researchers suggest that this interaction halts the cancer cell cycle before DNA replication, thereby inhibiting cancer cell proliferation.

While these findings are encouraging, the researchers caution that this is fundamental research using cell experiments. It does not establish a direct link between coffee consumption and colorectal cancer prevention. They advise against excessive coffee intake, noting that coffee contains other components and may not be suitable for everyone.